Free Cerebrovascular Symposium Spotlights Survivor Challenges
CINCINNATI"New Pathways, a free educational symposium for patients, caregivers and families who are coping with brain aneurysms, arteriovenous malformations or moyamoya disease, will be held Saturday, May 15, at the Radisson Hotel in Covington, Ky.
The event is co-hosted by the
Registration and a continental breakfast will begin at 8 a.m., and the opening lecture will begin at 8:30. Participants will have an opportunity to attend a breakout session devoted to the cerebrovascular condition that affects them.
The symposium will provide a unique opportunity for survivors of cerebrovascular disorders and their families to meet with other survivors, caregivers and healthcare professionals. The symposium will offer formal presentations and informational displays. Topics will include diagnosis, surgical and endovascular treatments, rehabilitation challenges, conquering headaches, caregiver tips and maintaining a positive attitude.
Featured speakers include:
- Joseph Broderick, MD, chairman of the neurology department at UC, research director of UCNI and a UC Health neurologist
- Mario Zuccarello, MD, professor and interim chairman of the neurosurgery department at UC and a Mayfield Clinic neurosurgeon
- Andrew Ringer, MD, director of endovascular neurosurgery at UC and a Mayfield Clinic neurosurgeon
Although the symposium is free, participants are asked to register in advance by calling (513) 569-5354 or by sending an e-mail to events@UCNeuroscience.com.
The Tri-State Brain Aneurysm Support Group, founded in 2002, provides information, educational materials and encouragement to survivors and their families and caregivers.
The Radisson Hotel is located at 668 W. Fifth St. in Covington. Parking in the hotel lot is free for participants.
Andrew Ringer, MD
Mario Zuccarello, MD, performed Amber Gray s complicated surgery.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.